[Value in pediatrics of a new delayed-action tetracycline: doxycycline].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D001772:Blood Cell Count; D001990:Bronchiolitis, Viral / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D009279:Naphthacenes / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D009281:Naphthalenes / Q000627:therapeutic use*; D010031:Otitis / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D012220:Rhinitis / Q000188:drug therapy; D013997:Time Factors; D014570:Urologic Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D009279:Naphthacenes; D009281:Naphthalenes
Intérêt en pédiatrie d'une nouvelle tétracycline à action prolongée: la doxycycline.